Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
Jazz Pharmaceuticals
Bayer
Rutgers, The State University of New Jersey
Hoffmann-La Roche
National Institutes of Health Clinical Center (CC)
University of California, Davis
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
Daiichi Sankyo
Mayo Clinic
I-Mab Biopharma US Limited
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
GlaxoSmithKline
Merck Sharp & Dohme LLC
University of California, Irvine
Elevation Oncology
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
Exelixis
National Institutes of Health Clinical Center (CC)
pharmaand GmbH
Hoffmann-La Roche
AstraZeneca
OncoNano Medicine, Inc.
OncXerna Theraputics, Inc.
National Institutes of Health Clinical Center (CC)
Main Line Health
Duke University
NRG Oncology
ExcellaBio LLC
Mary Crowley Medical Research Center
GOG Foundation
Cambridge University Hospitals NHS Foundation Trust
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Novartis
University of Oxford
Washington University School of Medicine
Takeda
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
The University of Texas Health Science Center at San Antonio
National Institutes of Health Clinical Center (CC)
Cancer Research UK
St. Luke's-Roosevelt Hospital Center
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.